This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / TransMedics Class Action Lawsuit Filed
Business class action

TransMedics Class Action Lawsuit Filed

Analysis based on 16 articles · First reported Feb 15, 2025 · Last updated Feb 27, 2025

Sentiment
-60
Attention
4
Articles
16
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The class action lawsuit against TransMedics, stemming from allegations of fraudulent practices and safety issues, has led to a significant decline in TransMedics' stock price. This event highlights increased regulatory scrutiny and potential financial liabilities for TransMedics, impacting investor confidence in the medical technology sector.

Medical Technology Healthcare
Event Summary

A class action lawsuit has been filed against TransMedics and its executives, alleging violations of the Securities Exchange Act of 1934. The lawsuit claims that TransMedics engaged in kickbacks, fraudulent overbilling, coercive tactics, and unsafe practices, while also lacking safety oversight. These allegations were brought to light by a letter from U.S. Representative Paul Gosar on February 21, 2024, which was reported by The Daily Caller, and further detailed in a report by Scorpion Capital on January 10, 2025. Both instances led to drops in TransMedics' stock price. Investors who purchased TransMedics securities between February 28, 2023, and January 10, 2025, have until April 15, 2025, to seek appointment as lead plaintiff.

Key Actions
100 Robbins Geller Rudman & Dowd LLP announced class action TransMedics
80 Scorpion Capital issued report TransMedics
70 Paul Gosar issued letter TransMedics
50 The Daily Caller reported on letter TransMedics
Entities Involved
stock
TransMedics
TransMedics is facing a class action lawsuit for alleged misconduct including kickbacks, fraudulent overbilling, unsafe practices, and lack of safety oversight, which has caused its stock price to fall.
Importance 100.0 Sentiment -70.0
priv
Robbins Geller Rudman & Dowd LLP
Robbins Geller Rudman & Dowd LLP is the law firm announcing and leading the class action lawsuit against TransMedics, representing investors who suffered losses.
Importance 70.0 Sentiment 50.0
priv
Scorpion Capital
Scorpion Capital issued a report accusing TransMedics of overbilling, coercive tactics, and providing rejected organs, leading to a further drop in TransMedics' stock price.
Importance 50.0 Sentiment 0.0
per
Paul Gosar
Paul Gosar, a U.S. Representative, issued a letter accusing TransMedics of misconduct, which contributed to the decline in TransMedics' stock price.
Importance 40.0 Sentiment 0.0
oth
The Daily Caller
The Daily Caller reported on Paul Gosar's letter accusing TransMedics of misconduct, further disseminating the negative news.
Importance 20.0 Sentiment 0.0
Relationships
TransMedics target ↔ Scorpion Capital TransMedics is the target of an activist short campaign by Scorpion Capital, which has publicly accused the company of u
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.